These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22451930)

  • 21. Meta-analysis of auditory P50 sensory gating in schizophrenia and bipolar disorder.
    Atagun MI; Drukker M; Hall MH; Altun IK; Tatli SZ; Guloksuz S; van Os J; van Amelsvoort T
    Psychiatry Res Neuroimaging; 2020 Jun; 300():111078. PubMed ID: 32361172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.
    Hazlett EA; Rothstein EG; Ferreira R; Silverman JM; Siever LJ; Olincy A
    Schizophr Res; 2015 Feb; 161(2-3):283-90. PubMed ID: 25482574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Determinants of Gating Functions: Do We Get Closer to Understanding Schizophrenia Etiopathogenesis?
    Rovný R; Besterciová D; Riečanský I
    Front Psychiatry; 2020; 11():550225. PubMed ID: 33324248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.
    Myles-Worsley M; Ord L; Blailes F; Ngiralmau H; Freedman R
    Biol Psychiatry; 2004 Apr; 55(7):663-7. PubMed ID: 15038993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does COMT val158met polymorphism influence P50 sensory gating, eye tracking or saccadic inhibition dysfunctions in schizophrenia?
    Demily C; Louchart-de-la-Chapelle S; Nkam I; Ramoz N; Denise P; Nicolas A; Savalle C; Thibaut F
    Psychiatry Res; 2016 Dec; 246():738-744. PubMed ID: 27825784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association study of polymorphisms in the alpha 7 nicotinic acetylcholine receptor subunit and catechol-o-methyl transferase genes with sensory gating in first-episode schizophrenia.
    Liu X; Hong X; Chan RC; Kong F; Peng Z; Wan X; Wang C; Cheng L
    Psychiatry Res; 2013 Oct; 209(3):431-8. PubMed ID: 23598060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia.
    Micoulaud-Franchi JA; Vaillant F; Lopez R; Peri P; Baillif A; Brandejsky L; Steffen ML; Boyer L; Richieri R; Cermolacce M; Bioulac S; Aramaki M; Philip P; Lancon C; Vion-Dury J
    Biol Psychol; 2015 Apr; 107():16-23. PubMed ID: 25766264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment.
    Oranje B; Aggernaes B; Rasmussen H; Ebdrup BH; Glenthøj BY
    Schizophr Bull; 2013 Mar; 39(2):472-80. PubMed ID: 22241164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between TCF4 and schizophrenia does not exert its effect by common nonsynonymous variation or by influencing cis-acting regulation of mRNA expression in adult human brain.
    Williams HJ; Moskvina V; Smith RL; Dwyer S; Russo G; Owen MJ; O'Donovan MC
    Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(7):781-4. PubMed ID: 21812098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tcf4 transgenic female mice display delayed adaptation in an auditory latent inhibition paradigm.
    Brzózka MM; Rossner MJ; de Hoz L
    Eur Arch Psychiatry Clin Neurosci; 2016 Sep; 266(6):505-12. PubMed ID: 26404636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking affects the association between cognitive impairment and P50 inhibition defects in patients with chronic schizophrenia: A case-control study.
    Wang DM; Xia LY; Zhou HX; Tian Y; Dai QL; Xiu MH; Chen DC; Wang L; Zhang XY
    Asian J Psychiatr; 2023 Jan; 79():103391. PubMed ID: 36516649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.
    Knott V; Millar A; Fisher D; Albert P
    Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auditory verbal hallucinations in schizophrenia correlate with P50 gating.
    Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ
    Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No effect of schizophrenia risk genes MIR137, TCF4, and ZNF804A on macroscopic brain structure.
    Cousijn H; Eissing M; Fernández G; Fisher SE; Franke B; Zwiers M; Harrison PJ; Arias-Vásquez A
    Schizophr Res; 2014 Nov; 159(2-3):329-32. PubMed ID: 25217366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia--gating of auditory-evoked potentials and prepulse inhibition.
    Broberg BV; Oranje B; Glenthøj BY; Fejgin K; Plath N; Bastlund JF
    Behav Brain Res; 2010 Dec; 213(2):142-7. PubMed ID: 20417666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naïve schizophrenia.
    Xia L; Wang D; Wei G; Wang J; Zhou H; Xu H; Tian Y; Dai Q; Xiu M; Chen D; Wang L; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110246. PubMed ID: 33453321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common variants at VRK2 and TCF4 conferring risk of schizophrenia.
    Steinberg S; de Jong S; ; Andreassen OA; Werge T; Børglum AD; Mors O; Mortensen PB; Gustafsson O; Costas J; Pietiläinen OP; Demontis D; Papiol S; Huttenlocher J; Mattheisen M; Breuer R; Vassos E; Giegling I; Fraser G; Walker N; Tuulio-Henriksson A; Suvisaari J; Lönnqvist J; Paunio T; Agartz I; Melle I; Djurovic S; Strengman E; ; Jürgens G; Glenthøj B; Terenius L; Hougaard DM; Ørntoft T; Wiuf C; Didriksen M; Hollegaard MV; Nordentoft M; van Winkel R; Kenis G; Abramova L; Kaleda V; Arrojo M; Sanjuán J; Arango C; Sperling S; Rossner M; Ribolsi M; Magni V; Siracusano A; Christiansen C; Kiemeney LA; Veldink J; van den Berg L; Ingason A; Muglia P; Murray R; Nöthen MM; Sigurdsson E; Petursson H; Thorsteinsdottir U; Kong A; Rubino IA; De Hert M; Réthelyi JM; Bitter I; Jönsson EG; Golimbet V; Carracedo A; Ehrenreich H; Craddock N; Owen MJ; O'Donovan MC; ; Ruggeri M; Tosato S; Peltonen L; Ophoff RA; Collier DA; St Clair D; Rietschel M; Cichon S; Stefansson H; Rujescu D; Stefansson K
    Hum Mol Genet; 2011 Oct; 20(20):4076-81. PubMed ID: 21791550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P50 sensory gating: impact of high vs. low schizotypal personality and smoking status.
    Wan L; Crawford HJ; Boutros N
    Int J Psychophysiol; 2006 Apr; 60(1):1-9. PubMed ID: 15955583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease.
    Navarrete K; Pedroso I; De Jong S; Stefansson H; Steinberg S; Stefansson K; Ophoff RA; Schalkwyk LC; Collier DA
    Am J Med Genet B Neuropsychiatr Genet; 2013 Jan; 162B(1):1-16. PubMed ID: 23129290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficits in trace fear memory in a mouse model of the schizophrenia risk gene TCF4.
    Brzózka MM; Rossner MJ
    Behav Brain Res; 2013 Jan; 237():348-56. PubMed ID: 23069005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.